Federal Register Notice: FDA is explaining the new direct-to-consumer (DTC) user fee program and asking companies to notify the agency within 30 calendar days if they intend to participate in the DTC user fee program during fiscal year (FY) 2008. The information gathered in response to this notice will be used to establish the FY 2008 fee that will be charged for each FY 2008 advisory review submission to FDA and to fund the operating reserve under the Food and Drug Administration Amendments Act of 2007. To view this notice, click here.